Alexza Pharmaceuticals shares are tanking in early trading after the company announced today that the U.S. Food and Drug Administration has not approved its AZ-004, an antipsychotic inhaled drug for treating agitation in schizophrenia or bipolar-disorder patients.
Continue reading Alexza Shares Sink as the FDA Denies Its Antipsychotic Drug
Alexza Shares Sink as the FDA Denies Its Antipsychotic Drug originally appeared on DailyFinance on Mon, 11 Oct 2010 10:05:00.
Filed Under: Company News, Investing, Health Care, Stocks in the News